BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma J, Boudewijns R, Sanchez-Felipe L, Mishra N, Vercruysse T, Buh Kum D, Thibaut HJ, Neyts J, Dallmeier K. Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice. Emerg Microbes Infect 2021;10:2279-90. [PMID: 34792431 DOI: 10.1080/22221751.2021.2008772] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Brunetti JE, Kitsera M, Muñoz-Fontela C, Rodríguez E. Use of Hu-PBL Mice to Study Pathogenesis of Human-Restricted Viruses. Viruses 2023;15. [PMID: 36680271 DOI: 10.3390/v15010228] [Reference Citation Analysis]
2 Wang HJ, Guo Y, He MJ, Liu ZY, Ye Q, Huang XY, Deng YQ, Li XF, Qin CF. Development of a Bicistronic Yellow Fever Live Attenuated Vaccine with Reduced Neurovirulence and Viscerotropism. Microbiol Spectr 2022;10:e0224622. [PMID: 35980184 DOI: 10.1128/spectrum.02246-22] [Reference Citation Analysis]
3 Ma J, Yakass MB, Jansen S, Malengier-Devlies B, Van Looveren D, Sanchez-Felipe L, Vercruysse T, Weynand B, Javarappa MPA, Quaye O, Matthys P, Roskams T, Neyts J, Thibaut HJ, Dallmeier K. Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models. EBioMedicine 2022;83:104240. [PMID: 36041265 DOI: 10.1016/j.ebiom.2022.104240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Baldon LVR, de Mendonça SF, Ferreira FV, Rezende FO, Amadou SCG, Leite THJF, Rocha MN, Marques JT, Moreira LA, Ferreira AGA. AG129 Mice as a Comprehensive Model for the Experimental Assessment of Mosquito Vector Competence for Arboviruses. Pathogens 2022;11:879. [DOI: 10.3390/pathogens11080879] [Reference Citation Analysis]